Trial Profile
Influence of tiotropium bromide (Spiriva) plus salbutamol versus salbutamol on the mucin secretion and sputum properties in subjects with a COPD exacerbation -TIBROMUC.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2011
Price :
$35
*
At a glance
- Drugs Ipratropium bromide (Primary) ; Salbutamol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms TIBROMUC
- 07 Jul 2011 New trial record